Investing Ideas
/
Global High Growth Potential Companies

Global High Growth Potential Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

8696

0 new

Companies with a Future performance score of at least 3, ordered by Future performance score.

8,696 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
FWRY Fawry for Banking Technology and Electronic PaymentsE	ج.م8.39	-1.3%	52.5%	ج.م28.6b	ج.م12.45	PE23.1x	E27.4%	n/a	Diversified Financials
RMDA Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)E	ج.م3.34	-1.5%	95.9%	ج.م5.0b	ج.م5.02	PE18.9x	E30.7%	2.0%	Pharmaceuticals & Biotech
AXSM Axsome Therapeutics	US$87.97	-2.0%	10.5%	US$4.2b	US$130.47	PS12.6x	E72.5%	n/a	Pharmaceuticals & Biotech
TGTX TG Therapeutics	US$33.50	8.2%	90.1%	US$4.6b	US$40.75	PS18.2x	E57.0%	n/a	Pharmaceuticals & Biotech
TVTX Travere Therapeutics	US$17.78	2.2%	88.9%	US$1.5b	US$27.40	PS7.6x	E72.5%	n/a	Pharmaceuticals & Biotech
ARES Ares Management	US$182.72	6.8%	52.4%	US$56.7b	US$185.31	PE85.3x	E38.4%	2.0%	Diversified Financials
CRDO Credo Technology Group Holding	US$72.02	7.4%	262.3%	US$11.9b	US$73.54	PS49x	E66.3%	n/a	Semiconductors
ALKT Alkami Technology	US$39.90	3.2%	63.5%	US$4.0b	US$44.60	PS12.7x	E102.7%	n/a	Software
ALNY Alnylam Pharmaceuticals	US$242.50	1.5%	23.9%	US$31.4b	US$299.11	PS14.9x	E70.3%	n/a	Pharmaceuticals & Biotech
SKS SKS Technologies Group	AU$1.78	4.7%	493.3%	AU$199.5m	AU$2.15	PE30.1x	E24.8%	0.6%	Capital Goods
ZVRA Zevra Therapeutics	US$8.56	0.2%	50.2%	US$458.5m	US$20.00	PS18.7x	E73.5%	n/a	Pharmaceuticals & Biotech
ONON On Holding	US$56.39	2.3%	101.7%	US$18.1b	US$59.48	PE128.8x	E29.4%	n/a	Consumer Durables
PRL Propel Holdings	CA$37.37	3.7%	188.1%	CA$1.4b	CA$44.28	PE23.1x	E37.6%	1.6%	Diversified Financials
PHM Pharma Mar	€79.90	1.8%	94.5%	€1.4b	€83.20	PE2253x	E56.2%	0.8%	Pharmaceuticals & Biotech
ICOP I.CO.P.. Società Benefit	€8.28	-0.5%	n/a	€228.8m	€9.80	PE45.3x	E49.2%	n/a	Capital Goods
CDR CD Projekt	zł187.30	0%	62.9%	zł18.7b	zł145.78	PE42.6x	E27.0%	0.5%	Media
WAYS Waystream Holding	SEK 15.86	0.9%	-41.9%	SEK 128.0m	SEK 36.50	PS1x	E113.3%	0%	Tech
ACE Ascelia Pharma	SEK 3.06	2.0%	-9.2%	SEK 294.1m	SEK 8.25	PB2.7x	E47.2%	n/a	Pharmaceuticals & Biotech
INIT Initiator Pharma	SEK 6.80	0%	-26.4%	SEK 382.5m	SEK 22.50	PB15.7x	E31.7%	n/a	Pharmaceuticals & Biotech
AGP Altea Green Power	€6.30	0%	-7.9%	€109.1m	€12.85	PE16.1x	E22.1%	n/a	Capital Goods
AFISH Arctic Fish Holding	NOK 71.00	0%	11.8%	NOK 2.3b	NOK 81.00	PE68.3x	E94.4%	n/a	Food, Beverage & Tobacco
NEWBRY Newbury Pharmaceuticals	SEK 3.68	4.5%	19.9%	SEK 89.3m	SEK 8.00	PS2.4x	E130.0%	n/a	Pharmaceuticals & Biotech
CADLR Cadeler	NOK 64.20	0.9%	36.8%	NOK 22.5b	NOK 82.90	PE208.1x	E70.4%	n/a	Capital Goods
MBTN Meyer Burger Technology	CHF 2.31	-4.3%	-98.4%	CHF 71.3m	CHF 6.03	PS0.8x	E109.3%	n/a	Semiconductors

Page 1 of 363